Home » Topics » Regulatory

Regulatory
RSS

FDA approves first vaccine for prevention of invasive pneumococcal disease in infants and toddlers

Feb. 18, 2000

Pharmacyclics' texaphyrins now claimed for use in macrophage-mediated conditions

Feb. 17, 2000

Transmucosal clemastine under study at Nastech for motion sickness

Feb. 16, 2000

Bio-Technology General obtains first marketing approval worldwide for HBV vaccine

Feb. 15, 2000

Ophthalmic antibacterial on the way to market in Japan

Feb. 15, 2000

FDA approves Actimmune for treatment of osteopetrosis

Feb. 14, 2000

Preclinical studies support potential new indication for tamsulosin

Feb. 14, 2000

Nastech claims formulations of sildenafil for nasal delivery

Feb. 11, 2000

Improved topical formulations of aciclovir developed at Recordati

Feb. 11, 2000

FDA approves Lotronex for IBS in women

Feb. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...